Unveiling the Digital Evolution of Molecular Tumor Boards
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Molecular tumor boards (MTBs) streamline cancer treatment by integrating molecular data. This research reviews current MTB processes, knowledge bases, and digital tools to improve personalized medicine delivery.
Area Of Science
- Oncology
- Bioinformatics
- Medical Informatics
Background
- Molecular tumor boards (MTBs) are crucial for personalized cancer treatment, integrating diverse data for individualized therapy recommendations.
- The complexity of heterogeneous data (clinical, genomic) and external resources (databases, literature) presents significant challenges in MTB workflows.
- Manual data processing and analysis in MTBs are time-consuming and require substantial human effort.
Purpose Of The Study
- To conduct a comprehensive literature review on Molecular Tumor Boards (MTBs).
- To analyze the current processes, common knowledge bases, and supporting tools utilized in MTB decision-making.
- To identify trends towards automation and digitalization in MTB workflows.
Main Methods
- Systematic literature search on Molecular Tumor Boards (MTBs).
- Analysis of existing MTB processes, data integration strategies, and knowledge management systems.
- Review of digital tools and automation solutions supporting MTB operations.
Main Results
- MTBs integrate patient clinical data with molecular variants for tailored treatment plans.
- Heterogeneous data sources necessitate significant effort for homogenization and rapid analysis.
- Automation and digitalization are increasingly adopted to enhance efficiency and reduce manual workload in MTBs.
- Tools aid in data visualization, providing refined overviews for board members.
Conclusions
- Automation and digitalization are key to optimizing MTB efficiency and reducing turnaround time for personalized treatment suggestions.
- Effective integration of diverse data sources and knowledge bases is critical for successful MTB operations.
- Continued development of supportive tools is essential for refining decision-making processes in molecular tumor boards.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...